Tony Sk Mok

25PUBLICATIONS
168CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersLiquid biopsiesTe whaikaha me te Māori (Māori and disability)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Jun 24, 2026
Retraction Note: Time-of-day immunochemotherapy in non-small cell lung cancer: a randomized phase 3 trial.

|Apr 10, 2026
First-Line Sacituzumab Govitecan Plus Pembrolizumab and Carboplatin in Metastatic Non-Small Cell Lung Cancer: Nonsquamous and Squamous Cohorts of the EVOKE-02 Study.

Jhanelle E Gray, Joel W Neal, Jyoti D Patel

|Mar 12, 2026
Aumolertinib with carboplatin-pemetrexed versus aumolertinib for nonsmall cell lung cancer with EGFR and concomitant tumor suppressor genes (ACROSS2): An open-label, multicenter, randomized phase 3 study.

Jian-Chun Duan, Jia Zhong, Bo-Yang Sun

|Feb 02, 2026
Time-of-day immunochemotherapy in non-small cell lung cancer: a randomized phase 3 trial.

Zhe Huang, Liang Zeng, Zhaohui Ruan

|Dec 08, 2025
Precise diagnosis of small invasive pulmonary nodules driven by single-cell immune signatures in peripheral blood.

Yang Xia, Yin Zhu, Sai Zhang

|Apr 29, 2025
D3S-001 in advanced solid tumors with KRAS<sup>G12C</sup> mutations: a phase 1 trial.

Byoung Chul Cho, Shun Lu, Myung Ah Lee

Pageof 5

Frequent Collaborators

6 joint publications

Yi-Long Wu

6 joint publications

Byoung Chul Cho

4 joint publications

Solange Peters

3 joint publications

Benjamin J Solomon